title: Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?
authors.affiliation: Regional coordination for Rare Diseases, AReS Puglia, Bari, Italy. annicchiarico.giuseppina@gmail.com.
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Annicchiarico
authors.affiliation: Interdisciplinary Department of Medicine, Rheumatology Unit, Policlinico of Bari, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lopalco
authors.affiliation: Department of Clinical and Experimental Medicine, University of Foggia, Italy.
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Morgese
authors.affiliation: Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Cantarini
authors.affiliation: Interdisciplinary Department of Medicine, Rheumatology Unit, Policlinico of Bari, Italy.
authors.forename: Florenzo
authors.initials: F
authors.lastname: Iannone
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D024143:Collagen Type VII / Q000235:genetics; D016108:Epidermolysis Bullosa Dystrophica / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D005808:Genes, Recessive; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009154:Mutation; D010641:Phenotype; D012008:Recurrence; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C569053:COL7A1 protein, human; D024143:Collagen Type VII; D007166:Immunosuppressive Agents; C541220:canakinumab